1
Methods: We introduced OETA for pituitary adenomas with a detailed technical description.
2
Clinical manifestations and outcomes of pituitary adenomas in children are not clearly defined.
3
Several investigators have reported Pit-1 gene expression in human pituitary adenomas.
4
We retrospectively reviewed MR images of 113 surgically proven pituitary adenomas.
5
This lesion is a rare complication of endoscopic transsphenoidal resections of pituitary adenomas.
6
However, these data are not suitable for human pituitary adenomas.
7
We thus investigated the expression of PD-L1 in pituitary adenomas.
8
In conclusion, in situ end-labeling showed that apoptosis mostly occurs in functioning pituitary adenomas.
9
These distances and angles can provide more accurate reference for surgeries in pituitary adenomas.
10
Results: All pituitary adenomas were totally removed under microscope.
11
A total of 23 patients with pituitary adenomas presenting with oculomotor nerve palsy were reviewed.
12
Objective: To construct a dually targeting gene therapy system for pituitary adenomas and investigate its effect.
13
Conclusions: The one-and-a-half nostril endoscopic transsphenoidal approach for pituitary adenomas is a simple and reliable technique.
14
The symptoms of headache, disorder of sight and visual field disappeared postoperatively in nonfunctional pituitary adenomas.
15
Thirty-one and five tags were only detected in para-tumor normal pituitary tissues and pituitary adenomas, respectively.
16
Compared with functional pituitary adenomas, little is known regarding the involvement of SPAs in metabolic disorders.
